Deeper Dive: Understanding Virios Therapeutics Inc (VIRI) Through its Various Ratios

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The price of Virios Therapeutics Inc (NASDAQ: VIRI) closed at $0.26 in the last session, up 4.42% from day before closing price of $0.25. In other words, the price has increased by $4.42 from its previous closing price. On the day, 1.28 million shares were traded. VIRI stock price reached its highest trading level at $0.27 during the session, while it also had its lowest trading level at $0.2355.


We take a closer look at VIRI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.66 and its Current Ratio is at 5.66. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 21 ’23 when Pridgen William bought 15,335 shares for $1.30 per share. The transaction valued at 19,992 led to the insider holds 52,045 shares of the business.

Duncan Gregory Scott bought 25,000 shares of VIRI for $31,245 on Aug 17 ’23. The CHIEF EXECUTIVE OFFICER now owns 57,461 shares after completing the transaction at $1.25 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VIRI now has a Market Capitalization of 7217053 and an Enterprise Value of 2627531.

Stock Price History:

The Beta on a monthly basis for VIRI is 1.65, which has changed by -0.810219 over the last 52 weeks, in comparison to a change of 0.2586832 over the same period for the S&P500. Over the past 52 weeks, VIRI has reached a high of $2.42, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is -23.79%, while the 200-Day Moving Average is calculated to be -52.52%.

Shares Statistics:

According to the various share statistics, VIRI traded on average about 1.11M shares per day over the past 3-months and 1472500 shares per day over the past 10 days. A total of 27.76M shares are outstanding, with a floating share count of 23.36M. Insiders hold about 15.84% of the company’s shares, while institutions hold 2.44% stake in the company. Shares short for VIRI as of 1715731200 were 100478 with a Short Ratio of 0.30, compared to 1713139200 on 214450. Therefore, it implies a Short% of Shares Outstanding of 100478 and a Short% of Float of 0.5499999999999999.

Earnings Estimates

The current rating of Virios Therapeutics Inc (VIRI) is the result of assessments by 2.0 analysts actively engaged in evaluating its market dynamics.On average, analysts expect EPS of -$0.07 for the current quarter, with a high estimate of -$0.07 and a low estimate of -$0.07, while EPS last year was -$0.08. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.07.

Analysts are recommending an EPS of between -$0.27 and -$0.27 for the fiscal current year, implying an average EPS of -$0.27. EPS for the following year is -$0.18, with 2.0 analysts recommending between -$0.16 and -$0.21.

Most Popular